Approval · Notice of Compliance 10534 · 2009
AVAMYS: Notice of Compliance 10534
Issued August 21, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10534
- Date
- August 21, 2009
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: Treatment of perennial allergic rhinitis in pediatrics (2 years to < 12 years of age)
- Therapeutic class
- Corticosteroid
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AVAMYS | Not yet assigned | — |
Medicinal ingredients
- FLUTICASONE FUROATE 27.5 MCG per ACT